AMP 2018: An Interview with Dr. Jonathan Rothberg

1 November 2018

Dr. Jonathan Rothberg is a man who needs little introduction, and is now receiving the Association of Molecular Pathology’s (AMP) Award for Excellence in Molecular Diagnostics Services. We spoke to him about his many achievements, his proudest moments, and the future of his fascinating field.

1 November 2018

AMP 2018: Supporting Cancer Sufferers With the Mesothelioma Cancer Alliance

Given that Front Line Genomics was started after its founder’s father was diagnosed with Mesothelioma, it’s naturally a cause that we care passionately about. To that end we sat down with the Mesothelioma Cancer Alliance (MCA), an organisation dedicated to providing resources, information, and support to individuals suffering from mesothelioma and other asbestos-related diseases and their families, to find out more about the great work they do and the challenges they face every day. 

1 November 2018

AMP 2018: Training and Education Opportunities at AMP

While the Annual Meeting & Expo is the pinnacle of the association’s educational calendar, AMP offers educational initiatives throughout the year in a variety of formats, many of which offer continuing education credit.

1 November 2018

AMP 2018: Precision Medicine Starts Here

The Association for Molecular Pathology (AMP) Annual Meeting & Expo is where the molecular diagnostics community gathers to advance clinical knowledge, discuss new discoveries, share recent successes, and showcase the latest technological advances in molecular medicine.

16 July 2018

Artificial Intelligence: Friend or Foe?

We are seeking to explore the true story of AI: where are we now, what do we need to overcome, and how should we integrate this technology within the genomics sphere?

5 July 2018

Shifting the Patient Paradigm

The Greenwood Genetic Center (GGC) has embarked on a novel program to leverage traditional and emerging genomic technologies, in the search for answers for undiagnosed patients. 

28 June 2018

Data From 1 Million

The All of Us Research Program is a key element of the Precision Medicine Initiative. Two years on, we take a look at what they have achieved, and how they plan on integrating their research into the U.S. healthcare system over the next ten years.